معرفی
Cheryl Barth is a Researcher in the Department of Internal Medicine at Yale School of Medicine. Her work focuses on the safety and efficacy of implantable cardiac devices, particularly in athletic populations. She has contributed to studies evaluating implantable cardioverter defibrillator (ICD) lead survival and sports participation guidelines for patients with ICDs. Her research emphasizes clinical outcomes, device longevity, and patient safety in high-activity settings. Collaborations include work with experts in cardiology, electrophysiology, and clinical research.
Notable publications include investigations into ICD lead survival in athletes (2021), safety of sports for ICD patients (2013), and multinational registry studies (2012). Her contributions advance clinical guidelines for managing cardiovascular device patients in active lifestyles.
